523 related articles for article (PubMed ID: 16014048)
1. Infusion of angiotensin II reduces loss of glomerular capillary area in the early phase of anti-Thy-1.1 nephritis possibly via regulating angiogenesis-associated factors.
Takazawa Y; Maeshima Y; Kitayama H; Yamamoto Y; Kawachi H; Shimizu F; Matsui H; Sugiyama H; Yamasaki Y; Makino H
Kidney Int; 2005 Aug; 68(2):704-22. PubMed ID: 16014048
[TBL] [Abstract][Full Text] [Related]
2. Regulation of angiogenic factors in angiotensin II infusion model in association with tubulointerstitial injuries.
Kitayama H; Maeshima Y; Takazawa Y; Yamamoto Y; Wu Y; Ichinose K; Hirokoshi K; Sugiyama H; Yamasaki Y; Makino H
Am J Hypertens; 2006 Jul; 19(7):718-27. PubMed ID: 16814127
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II infusion ameliorates the early phase of a mesangioproliferative glomerulonephritis.
Wenzel UO; Thaiss F; Helmchen U; Stahl RA; Wolf G
Kidney Int; 2002 Mar; 61(3):1020-9. PubMed ID: 11849457
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.
Masuda Y; Shimizu A; Mori T; Ishiwata T; Kitamura H; Ohashi R; Ishizaki M; Asano G; Sugisaki Y; Yamanaka N
Am J Pathol; 2001 Aug; 159(2):599-608. PubMed ID: 11485918
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
[TBL] [Abstract][Full Text] [Related]
6. Angiopoietin correlates with glomerular capillary loss in anti-glomerular basement membrane glomerulonephritis.
Yuan HT; Tipping PG; Li XZ; Long DA; Woolf AS
Kidney Int; 2002 Jun; 61(6):2078-89. PubMed ID: 12028448
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II regulation of vascular endothelial growth factor and receptors Flt-1 and KDR/Flk-1 in cyclosporine nephrotoxicity.
Shihab FS; Bennett WM; Isaac J; Yi H; Andoh TF
Kidney Int; 2002 Aug; 62(2):422-33. PubMed ID: 12110003
[TBL] [Abstract][Full Text] [Related]
8. Local actions of endogenous angiotensin II in injured glomeruli.
Ma J; Matsusaka T; Yang H; Kawachi H; Shimizu F; Isaka Y; Imai E; Kon V; Ichikawa I
J Am Soc Nephrol; 2004 May; 15(5):1268-76. PubMed ID: 15100367
[TBL] [Abstract][Full Text] [Related]
9. Dietary salt intake modulates progression of antithymocyte serum nephritis through alteration of glomerular angiotensin II receptor expression.
Suzuki H; Yamamoto T; Ikegaya N; Hishida A
Am J Physiol Renal Physiol; 2004 Feb; 286(2):F267-77. PubMed ID: 14559715
[TBL] [Abstract][Full Text] [Related]
10. Local delivery of angiotensin receptor blocker into the kidney ameliorates progression of experimental glomerulonephritis.
Mahmood J; Khan F; Okada S; Kumagai N; Morioka T; Oite T
Kidney Int; 2006 Nov; 70(9):1591-8. PubMed ID: 16985512
[TBL] [Abstract][Full Text] [Related]
11. Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes: role of the renin-angiotensin system.
Rizkalla B; Forbes JM; Cao Z; Boner G; Cooper ME
J Hypertens; 2005 Jan; 23(1):153-64. PubMed ID: 15643138
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor administration does not improve microvascular disease in the salt-dependent phase of post-angiotensin II hypertension.
Long DA; Mu W; Price KL; Roncal C; Schreiner GF; Woolf AS; Johnson RJ
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1248-54. PubMed ID: 16804104
[TBL] [Abstract][Full Text] [Related]
13. Role of bradykinin, nitric oxide, and angiotensin II type 2 receptor in imidapril-induced angiogenesis.
Li P; Kondo T; Numaguchi Y; Kobayashi K; Aoki M; Inoue N; Okumura K; Murohara T
Hypertension; 2008 Feb; 51(2):252-8. PubMed ID: 18086946
[TBL] [Abstract][Full Text] [Related]
14. Intussusceptive capillary growth is required for glomerular repair in rat Thy-1.1 nephritis.
Notoya M; Shinosaki T; Kobayashi T; Sakai T; Kurihara H
Kidney Int; 2003 Apr; 63(4):1365-73. PubMed ID: 12631352
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II modulates VEGF-driven angiogenesis by opposing effects of type 1 and type 2 receptor stimulation in the microvascular endothelium.
Carbajo-Lozoya J; Lutz S; Feng Y; Kroll J; Hammes HP; Wieland T
Cell Signal; 2012 Jun; 24(6):1261-9. PubMed ID: 22374305
[TBL] [Abstract][Full Text] [Related]
16. Activation of a local tissue angiotensin system in podocytes by mechanical strain.
Durvasula RV; Petermann AT; Hiromura K; Blonski M; Pippin J; Mundel P; Pichler R; Griffin S; Couser WG; Shankland SJ
Kidney Int; 2004 Jan; 65(1):30-9. PubMed ID: 14675034
[TBL] [Abstract][Full Text] [Related]
17. Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT1 and AT2 receptors.
Rizkalla B; Forbes JM; Cooper ME; Cao Z
J Am Soc Nephrol; 2003 Dec; 14(12):3061-71. PubMed ID: 14638905
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
[TBL] [Abstract][Full Text] [Related]
19. Activated mesangial cells induce glomerular endothelial cells proliferation in rat anti-Thy-1 nephritis through VEGFA/VEGFR2 and Angpt2/Tie2 pathway.
Zhao Y; Fu B; Chen P; Li Q; Ouyang Q; Zhang C; Cai G; Wu L; Chen X
Cell Prolif; 2021 Jun; 54(6):e13055. PubMed ID: 33987885
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor-stimulating endothelial cell growth and accelerating glomerular capillary repair in experimental progressive glomerulonephritis.
Mori T; Shimizu A; Masuda Y; Fukuda Y; Yamanaka N
Nephron Exp Nephrol; 2003; 94(2):e44-54. PubMed ID: 12845230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
